Ercan, A. B., Aronson, M., Fernandez, N. R., Chang, Y., Levine, A., Liu, Z. A., Negm, L., Edwards, M., Bianchi, V., Stengs, L., Chung, J., Al-Battashi, A., Reschke, A., Lion, A., Ahmad, A., Lassaletta, A., Reddy, A. T., Al-Darraji, A. F., Shah, A. C., … Tabori, U. (2024). Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study. The Lancet Oncology, 25(5), 668–682. https://doi.org/10.1016/s1470-2045(24)00026-3

Elez, E., Kopetz, S., Tabernero, J., Bekaii-Saab, T., Taieb, J., Yoshino, T., Manji, G., Fernandez, K., Abbattista, A., Zhang, X., & Morris, V. K. (2024). SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAF V600E-mutant mCRC. Future Oncology, 20(11), 653–663. https://doi.org/10.2217/fon-2022-1249

Abbass, M. A., Plesec, T., & Church, J. M. (2023). A Different Way to Think About Syndromes of Hereditary Colorectal Cancer. Diseases of the Colon & Rectum, 66(10), 1339–1346. https://doi.org/10.1097/dcr.0000000000002772

Joseph, G., Lindberg, N. M., Guerra, C., Hernandez, C., Karliner, L. S., Gilmore, M. J., Zepp, J., Rolf, B. A., Caruncho, M., Riddle, L., Kauffman, T. L., Leo, M. C., & Wilfond, B. S. (2023). Medical interpreter‐mediated genetic counseling for Spanish preferring adults at risk for a hereditary cancer syndrome. Journal of Genetic Counseling, 32(4), 870–886. Portico. https://doi.org/10.1002/jgc4.1695

Abbass, M. A., & Church, J. (2023). Contemporary surgical management of colorectal cancer in Lynch syndrome. Journal of Surgical Oncology, 127(8), 1259–1263. Portico. https://doi.org/10.1002/jso.27318

Zeng, C., Bastarache, L. A., Tao, R., Venner, E., Hebbring, S., Andujar, J. D., Bland, H. T., Crosslin, D. R., Pratap, S., Cooley, A., Pacheco, J. A., Christensen, K. D., Perez, E., Zawatsky, C. L. B., Witkowski, L., Zouk, H., Weng, C., Leppig, K. A., Sleiman, P. M. A., … Denny, J. C. (2022). Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. JAMA Oncology, 8(6), 835. https://doi.org/10.1001/jamaoncol.2022.0373